Activating Compound | Comment | Organism | Structure |
---|---|---|---|
plasminogen activator inhibitor-1 | dose-dependently facilitates the dissociation of membrane-retained tPA and increases the amounts of tPA-plasminogen activator inhibitor-1 high-molecular-weight complexes in the medium | Homo sapiens |
Cloned (Comment) | Organism |
---|---|
subcloned into NheI/BamHI sites in GFP3.1 | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
S478A | efficacy of expression of the mutant and wild-type is similar, but the mutant does not appear in the culture medium after 24 h either complexed with plasminogen activator inhibitor-1 or in the free form. Intracellular distribution is indistinguishable to the wild-type, but it is present at higher concentrations than the wild-type near the plasma membrane | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
membrane | exocytosed tPA-GFP is retained at the membrane surface without retrieval for more than 5 min in a vascular endothelial cell-specific manner. FnEK1K2 domains are responsible for binding of tPA-GFP to the membrane surface | Homo sapiens | 16020 | - |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
147000 | - |
by Western blot analysis or by anti-GFP antibody, tPA-GFP-plasminogen activator inhibitor-1 complex | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
EAhy 926 cell | vascular endothelial cell line producing GFP-tagged tPA | Homo sapiens | - |
granule cell | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
Glu-plasminogen + H2O | - |
Homo sapiens | plasmin + ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
Tissue plasminogen activator | - |
Homo sapiens |
tPA | - |
Homo sapiens |